3   Kidney disease patients Normal Total number 147 20 Positive number 133 2 Positive rate 90.5% 10.0% Most of the patients were positive for proteinuria with a substantial amount of

urine proteins; the IgA–uromodulin buy Flavopiridol complex was found at various amounts, sometimes at high levels even though they were not diagnosed as IgAN (Table 1A). On the other hand, the ratio of the IgA–uromodulin complex compared to total urine protein was only high in cases of IgAN and not in other cases. In detail, the concentration of the urine protein of the specimen material that showed measurements higher than the cut-off value in urine was measured by the pyrogallol red method [19]. With the exception of one sample in which the concentration of the urine protein was below the detection limit, the amount of the IgA–uromodulin complex that had been obtained by the above-mentioned method was divided by the urine protein concentration, and the value of the complex for buy LXH254 each urine protein amount was calculated. In other words, the concentration of the IgA–uromodulin complex adjusted for urinary creatinine was divided by a urine protein concentration adjusted for urinary creatinine; the results are shown in Figure 5. Samples from eighty-five IgAN patients and from 47 kidney disease patients (other than IgAN) were able to be clearly distinguished

by comparing the value of the complex in the urine protein. Moreover, the ROC analysis of the samples from the 47 kidney disease patients (other than IgAN) and the samples from the 85 IgAN patients created the ROC curve shown in Fig. 6. The cut-off value calculated from learn more the ROC curve was 2.45. The result of the positive rates of the 47 kidney disease patient samples (other than IgAN) and the 85 IgAN patient samples from the cut-off value is shown in Table 4. Seventy-nine samples of the 85 IgAN patient samples were positive (92.9%) and 20 samples of the 47 kidney disease patients were positive (42.6%) as shown in Table 4, and both were able to be distinguished clearly. Sensitivity at that time was 92.9%, specificity was

57.4%, and diagnosis efficiency was 80.3%. Fig. 5 Distribution chart of the value of measurements that detect the IgA–uromodulin complex in urine by ELISA for each amount of urine Nintedanib (BIBF 1120) protein. Cut-off line is drawn by ROC analysis in Fig. 6. 132 samples (133 ELISA-positive kidney disease samples except for one sample below the detection limit of pyrogallol red method) were analyzed. They included 17 MN, 5 SLE, 4 FGS, 3 MCNS, 5 DMN, 13 other kidney diseases and 85 IgAN Fig. 6 Result of the ROC analysis of the value of measurements that detect the IgA–uromodulin complex in urine by ELISA for each amount of urine protein in Fig. 5 Table 4 Positive rate of IgAN and other kidney diseases by ELISA for the IgA–uromodulin complex for each amount of urine protein in Fig. 5   IgAN Other kidney diseases Total number 85 47 Positive number 79 20 Positive rate 92.9% 42.